ThinkSabio

$ACRS

$3.66▲ -6.6% YTD

9 SEC 13D/G filings tracked · Last updated Nov 16, 2026

Filing History
News
ACRS ▼ -6.6% - Aclaris Therapeutics, Inc.
CP $3.66▲ -6.6%Nov 16, 2026 · ThinkSabio Blog

$ACRS CGON LXEO SMMT LXEO SMMT ACRS CGON - Biotech's Monday Split: Two Trial Wins, One Trial Miss and an FDA Rejection…

News
ACRS ▼ -18.4% - Aclaris Therapeutics, Inc.
CP $3.20▲ -18.4%Nov 16, 2026 · ThinkSabio Blog

$ACRS Announces Top Line Phase 2 Results for its Anti-TSLP Monoclonal Antibody Bosakitug (ATI-045) in Atopic Dermatitis - The ADMIRATION Trial Did Not…

News
ACRS ▼ -6.0% - Aclaris Therapeutics, Inc.
CP $3.76▲ -6.0%Nov 16, 2026 · ThinkSabio Blog

$ACRS - Aclaris Therapeutics Initiates Phase 2b Trial of Modzatinib (ATI-2138) in Lichen Planus (LP)…

News
ACRS ▼ -6.0% - Aclaris Therapeutics, Inc.
CP $3.76▲ -6.0%Nov 16, 2026 · ThinkSabio Blog

$ACRS - Aclaris Therapeutics Announces Top Line Phase 2 Results for its Anti-TSLP Monoclonal Antibody Bosakitug (ATI-045) in Atopic Dermatitis (AD)…

News
ACRS ▲ +1.8% - Aclaris Therapeutics, Inc.
CP $4.42▲ +1.8%Nov 12, 2026 · ThinkSabio Blog

$ACRS - Aclaris Therapeutics to Participate in the Jefferies Global Healthcare Conference…

News
ACRS ▲ +3.8% - Aclaris Therapeutics, Inc.
CP $3.82▲ +3.8%Nov 5, 2026 · ThinkSabio Blog

$ACRS - Aclaris Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate and Clinical Update…

News
ACRS ▼ -3.4% - Aclaris Therapeutics, Inc.
CP $3.66▲ -3.4%Oct 27, 2026 · ThinkSabio Blog

$ACRS - Aclaris Therapeutics Announces Pricing of $50.0 Million Offering of Common Stock and Pre-Funded Warrants…

News
ACRS ▼ -4.0% - Aclaris Therapeutics, Inc.
CP $3.64▲ -4.0%Oct 27, 2026 · ThinkSabio Blog

$ACRS - Aclaris Therapeutics Announces Positive Phase 1b Proof-of-Concept Primary Analysis Results for its Anti-TSLP/IL-4R? Bispecific ATI-052 in Atop…

SEC 13D/G
ACRS - Aclaris Therapeutics, Inc. - SEC Filing Update (21-SEP-2026) | ThinkSabio - Stocks Simplified
$5.57▲ 92.07%Sep 21, 2026 · ThinkSabio Blog

$ACRS SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #ACRS Aclaris Therapeutics, Inc. : $5.57 Sector: Healthcare | YT…